Timothy Walbert 1985 graduate of Catasauqua High School in Catasauqua, PA is on Classmates.com. See pictures, plan your class reunion and get caught up with Timothy and other high ...
Timothy Walbert's Public Profile on Plaxo. Plaxo helps members like Timothy Walbert keep in touch with the people who really matter, helping them to connect, keep each other's ...
The trial failure does not change Horizon's M&A appetite, Chief Executive Timothy Walbert said on a conference call with analysts, adding that recent acquisitions would more than offset the growth the company would have seen by selling Actimmune to FA patients.
Date: Dec 08, 2016
Category: Business
Source: Google
Horizon slumps after phase 3 Friedreich's ataxia trial flops
While the results were not what we hoped for, this is the very reason why research and development is importantto find answers that may help inform future research, Horizon CEO Timothy Walbert said in a statement.
Date: Dec 08, 2016
Category: Business
Source: Google
Horizon Pharma in $800M Raptor rare disease buy, but pipeline beset by failures
The proposed acquisition of Raptor furthers our commitment to helping people with rare diseases and is a significant step in advancing our strategy to expand our rare disease business, said Timothy Walbert, chairman, president and CEO of Horizon.
Date: Sep 12, 2016
Category: Business
Source: Google
What's a billionaire biotech CEO worth? Soon-Shiong's price is $148M
nks as one of the biggest ever, and it dwarfs what most of the top-paid execs get. Last year the highest paid CEO in biopharma was Regenerons ($REGN) Len Schleifer at $42 million. And this year the highest paid exec to date has been Horizons Timothy Walbert, who scored a whopping $93 million.
Date: Apr 28, 2016
Category: Business
Source: Google
Horizon scoops up Hyperion and its rare disease portfolio for $1.1B
Already approved by both companies' boards, the Hyperion acquisition is expected to add $100 million to Horizon's adjusted EBITDA in 2016, including cost savings of more than $50 million, Horizon CEO Timothy Walbert said in a statement.
Date: Mar 30, 2015
Category: Business
Source: Google
Horizon Pharma Updates On FDA Committee Meeting On Cardiovascular Risk ...
individuals respond differently to NSAIDs, we make available two prescription strength NSAID options, Vimovo and Duexis, both of which have demonstrated a significant reduction in gastrointestinal ulcers, allowing prescribers the ability to treat a broad range of arthritis patients," said Timothy Walbert
Date: Feb 11, 2014
Category: Health
Source: Google
Horizon Drops as Investors Doubt Company's Marketing
We are extremely pleased the FDA has approved Rayos for abroad range of indications, Timothy Walbert, president andchief executive officer of Horizon, said in the statement. Ourinitial focus will be on the launch of Rayos in rheumatologicdiseases such as rheumatoid arthritis and polymyalgia r
"This is a huge milestone for the company, with two launches in one year," said Timothy Walbert, president and chief executive officer. "Not many big companies can get two products approved in a year."